Fred Alger Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Sell |
|
|||||
|
2025
Q1 | $2.04M | Buy |
|
|||||
|
2024
Q4 | $1.7M | Sell |
|
|||||
|
2024
Q3 | $1.87M | Sell |
|
|||||
|
2024
Q2 | $2.43M | Sell |
|
|||||
|
2024
Q1 | $2.72M | Sell |
|
|||||
|
2023
Q4 | $3.22M | Sell |
|
|||||
|
2023
Q3 | $3.62M | Sell |
|
|||||
|
2023
Q2 | $4.13M | Sell |
|
|||||
|
2023
Q1 | $12.9M | Buy |
|
|||||
|
2022
Q4 | $7.52M | Buy |
|
|||||
|
2022
Q3 | $3.28M | Sell |
|
|||||
|
2022
Q2 | $5.92M | Sell |
|
|||||
|
2022
Q1 | $9.47M | Sell |
|
|||||
|
2021
Q4 | $19.1M | Buy |
|
|||||
|
2021
Q3 | $3.16M | Buy |
|
|||||
|
2021
Q2 | $3.18M | Buy |
|
|||||
|
2021
Q1 | $2.3M | Sell |
|
|||||
|
2020
Q4 | $39.1M | Buy |
|
|||||
|
2020
Q3 | $28.9M | Sell |
|
|||||
|
2020
Q2 | $152M | Buy |
|
|||||
|
2020
Q1 | $1.52M | Buy |
|
|||||
|
2019
Q4 | $936K | Buy |
|
|||||
|
2019
Q3 | $455K | Sell |
|
|||||
|
2019
Q2 | $1.71M | Buy |
|
|||||
|
2019
Q1 | $1.46M | Sell |
|
|||||
|
2018
Q4 | $58.6M | Sell |
|
|||||
|
2018
Q3 | $82.8M | Sell |
|
|||||
|
2018
Q2 | $91.8M | Buy |
|
|||||
|
2018
Q1 | $75.8M | Sell |
|
|||||
|
2017
Q4 | $91.3M | Buy |
|
|||||
|
2017
Q3 | $95M | Sell |
|
|||||
|
2017
Q2 | $93.5M | Sell |
|
|||||
|
2017
Q1 | $97.7M | Buy |
|
|||||
|
2016
Q4 | $89.9M | Sell |
|
|||||
|
2016
Q3 | $152M | Buy |
|
|||||
|
2016
Q2 | $112M | Buy |
|
|||||
|
2016
Q1 | $102M | Buy |
|
|||||
|
2015
Q4 | $39.7M | Sell |
|
|||||
|
2015
Q3 | $67.3M | Sell |
|
|||||
|
2015
Q2 | $118M | Buy |
|
|||||
|
2015
Q1 | $71M | Buy |
|
|||||
|
2014
Q4 | $6.84M | Buy |
|
|||||
|
2014
Q3 | $4.95M | Sell |
|
|||||
|
2014
Q2 | $6.52M | Sell |
|
|||||
|
2014
Q1 | $14.6M | Sell |
|
|||||
|
2013
Q4 | $19M | Buy |
|
|||||
|
2013
Q3 | $7.82M | Buy |
|
|||||
|
2013
Q2 | $1.96M | Buy |
|